Exclusions from patentability under section 3 including living organisms and traditional knowledge

Introduction

Section 3 of the Indian Patents Act, 1970 identifies inventions that are not considered patentable under Indian law. It establishes limitations on patent protection to ensure that patents are granted only for genuine technological innovations and not for discoveries, naturally occurring substances, traditional knowledge or subject matter that conflicts with public interest.

These exclusions are particularly important in biotechnology, agriculture, pharmaceuticals, genetic engineering and traditional medicine. Scientific developments involving living organisms and biological materials raise questions about ownership of natural resources, commercial exploitation of traditional knowledge and protection of biodiversity.

Section 3 therefore plays an important role in balancing technological innovation, public health, environmental protection and India's traditional knowledge heritage.

Meaning and Purpose of Section 3

Section 3 provides a list of subject matters that are not inventions within the meaning of the Patents Act. Even if an applicant presents a scientific or technical development, patent protection may be refused when the claimed subject matter falls within one of these exclusions.

The major objectives are:

Preventing monopolisation of discoveries that already exist in nature.

Protecting traditional knowledge from unauthorised commercial appropriation.

Maintaining public access to essential biological resources.

Preventing patents over certain forms of life and natural biological processes.

Ensuring that patent protection is limited to genuine inventive contributions.

Exclusion of Living Organisms Under Section 3

Section 3(j) is particularly significant in biotechnology. It excludes plants and animals, in whole or any part thereof, other than microorganisms, but includes seeds, varieties and species and essentially biological processes for production or propagation of plants and animals.

This provision creates an important distinction between patentable technological inventions and naturally occurring biological materials.

1. Plants and Animals

Plants and animals, including their parts, seeds, varieties and species, are generally excluded from patentability under Section 3(j). Therefore, an applicant cannot obtain a patent merely by identifying or isolating a naturally existing plant or animal characteristic.

However, separate protection may be available under the Protection of Plant Varieties and Farmers' Rights Act, 2001, subject to its requirements.

2. Microorganisms

Microorganisms are expressly excluded from the general living-organism exclusion in Section 3(j). This means that certain genetically modified or otherwise engineered microorganisms may be patentable if they satisfy the other requirements of patent law.

However, merely discovering a naturally occurring microorganism does not automatically establish patentability. Sections 3(c) and 3(d), where applicable, and the requirements of novelty and inventive step must also be considered.

3. Essentially Biological Processes

Section 3(j) excludes essentially biological processes for the production or propagation of plants and animals. Conventional breeding and natural reproduction processes therefore generally cannot receive patent protection.

A genuinely technical or microbiological process may require separate examination to determine whether it falls within the exclusion.

Traditional Knowledge and Section 3(p)

Section 3(p) excludes inventions that are effectively traditional knowledge or an aggregation or duplication of known properties of traditionally known components.

Traditional knowledge includes knowledge developed and maintained by local and indigenous communities over generations. It may concern medicinal plants, agricultural practices, herbal preparations, natural products and traditional healing methods.

For example, the traditional use of turmeric for wound healing cannot become a new patentable invention merely because an applicant describes the already-known use in scientific language.

Similarly, the known medicinal properties of neem cannot be monopolised through a patent application that merely repeats traditional knowledge.

The purpose of Section 3(p) is to prevent biopiracy and protect communities against the unauthorised commercial appropriation of established traditional knowledge.

Other Relevant Exclusions Under Section 3

Several additional provisions are important in biotechnology and biological research.

Section 3(c): Excludes the mere discovery of a scientific principle or formulation of an abstract theory, as well as the discovery of any living thing or non-living substance occurring in nature.

Section 3(d): Excludes the mere discovery of a new form of a known substance unless it results in enhancement of the known efficacy of that substance. This provision is particularly important in pharmaceutical patents.

Section 3(e): Excludes a substance obtained by a mere admixture resulting only in the aggregation of the properties of its components.

Section 3(i): Excludes methods of medical treatment, surgical treatment, diagnostic methods and therapeutic treatment of human beings or animals.

Section 3(j): Excludes specified plants, animals and essentially biological processes, subject to the microorganism exception.

Section 3(p): Excludes traditional knowledge and the duplication or aggregation of known properties of traditionally known components.

Relationship With Traditional Knowledge and Biodiversity Laws

India has developed additional legal mechanisms to protect biological resources and traditional knowledge.

The Biological Diversity Act, 2002 provides a framework for conservation, sustainable use and fair benefit-sharing arising from biological resources. Its access and intellectual property provisions are relevant to commercial research involving Indian biological resources.

The Protection of Plant Varieties and Farmers' Rights Act, 2001 recognises plant variety protection while providing specific rights to farmers and breeders.

The Traditional Knowledge Digital Library (TKDL), developed by the Government of India, helps patent offices identify existing traditional medicinal knowledge and prevent the grant of patents over already-known information.

Important Case Laws

1. Novartis AG v. Union of India (2013)

The Supreme Court considered the patentability of the beta-crystalline form of imatinib mesylate, a cancer medicine. The Court rejected the patent application because the applicant failed to establish the enhanced therapeutic efficacy required under Section 3(d).

Although the case primarily concerned pharmaceutical patentability, it demonstrates the importance of preventing patents based merely on minor modifications of known substances.

2. Dimminaco A.G. v. Controller of Patents and Designs (2002)

The Calcutta High Court considered a patent application involving a process for preparing a live vaccine containing an active microorganism. The Patent Office had rejected the application because the final product contained a living organism.

The Court held that a process did not become unpatentable merely because its end product contained a living organism. This judgment is important for understanding the patentability of biotechnological processes involving microorganisms.

3. Monsanto Technology LLC v. Nuziveedu Seeds Ltd. (2019)

The Supreme Court considered a dispute involving Bt cotton technology and patent protection. It set aside the Delhi High Court's decision on the maintainability of the patent-related claims and remanded the matter for appropriate proceedings.

The case is relevant to disputes concerning genetically modified seeds, biotechnology patents and the relationship between patent protection and plant variety legislation. It did not finally determine the general patentability of all genetically modified plants.

4. Turmeric Patent Case (University of Mississippi Medical Center, US Patent No. 5,401,504)

The United States Patent and Trademark Office granted a patent concerning the use of turmeric for wound healing. The Council of Scientific and Industrial Research (CSIR), India, challenged the patent by presenting evidence of existing traditional knowledge.

The patent was subsequently revoked because the claimed use lacked novelty in light of prior knowledge. Although this was a US patent dispute rather than an Indian court judgment, it became an important example of defensive protection against biopiracy.

5. Neem Patent Case (European Patent No. 0436257)

A patent concerning the fungicidal use of neem was challenged by several organisations, including Indian representatives. The European Patent Office ultimately revoked the patent because the claimed invention lacked novelty and involved knowledge already available through traditional practices.

The dispute demonstrated the importance of documenting traditional knowledge to prevent its unauthorised appropriation.

Challenges in Implementation

Despite the statutory exclusions, several challenges remain. Patent offices may find it difficult to distinguish genuine biotechnological inventions from discoveries of naturally occurring biological materials.

Traditional knowledge may be undocumented, orally transmitted or available only within particular communities. This creates difficulties in establishing prior art.

Other challenges include:

Identifying the contribution of traditional communities.

Preventing biopiracy involving medicinal plants and genetic resources.

Distinguishing technical innovation from natural biological processes.

Coordinating patent law with biodiversity and plant variety legislation.

Ensuring that patent examination uses reliable scientific evidence.

Conclusion

Section 3 of the Patents Act, 1970 plays a significant role in preventing inappropriate monopolisation of biological materials and traditional knowledge. Sections 3(c), 3(d), 3(j) and 3(p) are particularly important for biotechnology and genetic research.

Judgments such as Dimminaco A.G. v. Controller of Patents and Designs and Novartis AG v. Union of India clarify important boundaries of biotechnology and pharmaceutical patent protection. The turmeric and neem disputes further demonstrate the importance of protecting traditional knowledge against biopiracy.

Ultimately, India's patent framework seeks to encourage genuine scientific innovation while preserving biodiversity, farmers' interests, public access to biological resources and the rights of traditional knowledge holders.